As infection with CagA-expressing strains of H. pylori is associated with worse clinical outcome in patients, namely higher rates of peptic ulcer disease and gastric cancer [46], [47], [48], [49], we sought to determine if DFMO treatment could affect the production and function of this bacterial protein. This evidence concerns the gene S100A8 and gastric cancer.